Basaloid Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Basaloid Carcinoma

histology

Identifier: CI-CAN-00000480
Entity page: /cancer/basaloid-carcinoma ↗
Edges: 17

Neighbours: 9 drugs8 trials
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Basaloid Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived9 of 9
→ investigated in trials for	Nivolumabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Basaloid Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—

Basaloid Carcinoma studied in …STUDIED_INderived8 of 8
→ studied in	NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Anal Basaloid Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04444921Phase 3 · active not recruiting EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Anal Basaloid Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03233711Phase 3 · active not recruiting Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Anal Basaloid Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03952585Phase 2/Phase 3 · active not recruiting De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Basaloid Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03799445Phase 2 · terminated Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Oropharyngeal Basaloid Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03422536Phase 2 · completed Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Head and Neck Basaloid Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02560298Phase 2 · unknown Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Anal Basaloid Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00570674Phase 1/Phase 2 · terminated Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Basaloid Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →